Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.25−0.35 (-0.34%)
Close on Nov 12, 2026Market cap $6.61BP/E 25.0Yield –
Lantheus profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Lantheus's profit margin for the twelve months ending Sep 30, 2026 was 17.3%. For fiscal 2025 it was 15.2%, against 20.4% the year before. The highest annual figure on record is 37.2% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.2% | −5.2 |
| FY2024 | Dec 31, 2024 | 20.4% | −4.8 |
| FY2023 | Dec 31, 2023 | 25.2% | +22.2 |
| FY2022 | Dec 31, 2022 | 3.0% | +19.8 |
| FY2021 | Dec 31, 2021 | -16.8% | −12.8 |
| FY2020 | Dec 31, 2020 | -4.0% | −13.1 |
| FY2019 | Dec 31, 2019 | 9.1% | −2.7 |
| FY2018 | Dec 31, 2018 | 11.8% | −25.4 |
| FY2017 | Dec 31, 2017 | 37.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 5.7% | −1.5 |
| Q2 FY2026 | Jun 30, 2026 | 19.3% | −1.5 |
| Q1 FY2026 | Mar 31, 2026 | 31.4% | +11.8 |
| Q4 FY2025 | Dec 31, 2025 | 13.3% | +16.3 |
| Q3 FY2025 | Sep 30, 2025 | 7.2% | −27.4 |
| Q2 FY2025 | Jun 30, 2025 | 20.8% | +5.1 |
| Q1 FY2025 | Mar 31, 2025 | 19.6% | −15.9 |
| Q4 FY2024 | Dec 31, 2024 | -3.0% | −32.2 |
| Q3 FY2024 | Sep 30, 2024 | 34.6% | −6.6 |
| Q2 FY2024 | Jun 30, 2024 | 15.8% | −13.5 |
| Q1 FY2024 | Mar 31, 2024 | 35.4% | +36.4 |
| Q4 FY2023 | Dec 31, 2023 | 29.2% | +74.5 |
| Q3 FY2023 | Sep 30, 2023 | 41.2% | +15.7 |
| Q2 FY2023 | Jun 30, 2023 | 29.3% | +10.0 |
| Q1 FY2023 | Mar 31, 2023 | -0.9% | −21.5 |
| Q4 FY2022 | Dec 31, 2022 | -45.3% | −14.2 |
| Q3 FY2022 | Sep 30, 2022 | 25.6% | +38.7 |
| Q2 FY2022 | Jun 30, 2022 | 19.2% | +45.6 |
| Q1 FY2022 | Mar 31, 2022 | 20.6% | +10.8 |
| Q4 FY2021 | Dec 31, 2021 | -31.0% | −27.4 |
| Q3 FY2021 | Sep 30, 2021 | -13.1% | −5.9 |
| Q2 FY2021 | Jun 30, 2021 | -26.4% | −15.8 |
| Q1 FY2021 | Mar 31, 2021 | 9.7% | +6.1 |
| Q4 FY2020 | Dec 31, 2020 | -3.6% | −15.3 |
| Q3 FY2020 | Sep 30, 2020 | -7.2% | −12.9 |
| Q2 FY2020 | Jun 30, 2020 | -10.6% | −18.1 |
| Q1 FY2020 | Mar 31, 2020 | 3.7% | −7.8 |
| Q4 FY2019 | Dec 31, 2019 | 11.7% | −3.7 |
| Q3 FY2019 | Sep 30, 2019 | 5.7% | −4.8 |
| Q2 FY2019 | Jun 30, 2019 | 7.5% | −3.9 |
| Q1 FY2019 | Mar 31, 2019 | 11.5% | +1.6 |
| Q4 FY2018 | Dec 31, 2018 | 15.4% | −104.1 |
| Q3 FY2018 | Sep 30, 2018 | 10.4% | −0.2 |
| Q2 FY2018 | Jun 30, 2018 | 11.4% | −3.9 |
| Q1 FY2018 | Mar 31, 2018 | 9.9% | +4.9 |
| Q4 FY2017 | Dec 31, 2017 | 119.6% | +113.0 |
| Q3 FY2017 | Sep 30, 2017 | 10.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 15.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 5.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 6.5% | – |
See a number that looks wrong?